APhA Expresses Concerns Over Changes in Hepatitis B Vaccine Policy
The American Pharmacists Association (APhA) has voiced significant concern regarding the recent decision made by the CDC's Advisory Committee on Immunization Practices (ACIP) to eliminate the universal recommendation for administering the hepatitis B vaccine birth dose for infants in the United States. This decision represents a considerable step back from a successful public health initiative that has been in effect since 1991.
The introduction of the universal birth-dose recommendation has resulted in a significant decline in acute hepatitis B virus (HBV) infections among infants and young children. This change is crucial as it has been instrumental in preventing numerous children from developing chronic infections that could lead to serious health implications later in life. The hepatitis B vaccine is recognized for its safety and effectiveness, serving as the most reliable approach to avert chronic HBV infections. Even infants born to mothers who do not carry HBV are still at risk due to potential exposure from infected individuals in their homes, such as caregivers and siblings. This highlights the essential role of universal vaccination.
Brigid Groves, PharmD, MS, the vice president of professional affairs at APhA, stated, "Pharmacists have long been involved in preventing disease transmission through vaccine advocacy and administration, including the hepatitis B vaccine. We remain committed to safeguarding patients throughout their lives. The scientific evidence underscores that administering the hepatitis B birth dose saves lives, and no new data supports the withdrawal of this vital protection."
It is alarming to note that newborns infected with HBV have a 90% chance of becoming chronic carriers. Furthermore, one out of four infants diagnosed at birth may ultimately die due to HBV-related liver complications or liver cancer. Young children who contract HBV face an alarming 20% to 50% risk of developing a lifelong chronic infection. These severe consequences, along with the extensive treatments they necessitate, can be effectively prevented through timely vaccination.
APhA advocates strongly for maintaining the established and evidence-based childhood immunization schedule, which includes the HepB birth dose that has consistently demonstrated both safety and effectiveness.
The Importance of Hepatitis B Vaccination in Adults
Beyond childhood vaccinations, APhA emphasizes the necessity of hepatitis B vaccination for adults as well. The ACIP continues to advocate for the vaccination series for all individuals aged 19 to 59, older adults with specific risk factors, and any adult expressing a desire to get vaccinated. Hepatitis B vaccines are safe, effective, and generally covered by health insurance plans.
APhA's Ongoing Commitment
The APhA will persist in its advocacy for evidence-based immunization policies that prioritize the health and safety of patients and communities across the nation. Their role as a leading voice in pharmacy emphasizes the importance of vaccines in disease prevention, particularly concerning hepatitis B.
About the American Pharmacists Association
The APhA stands as the singular organization dedicated to advancing the pharmacy profession as a whole. Based in Washington, DC, APhA takes the lead in supporting pharmacists, student pharmacists, and pharmacy technicians in optimizing medication use and enhancing patient health outcomes. They ensure that patients have access to pharmacists' expertise and care through effective advocacy, high-quality education, practical tools and resources, the dissemination of scientific evidence, and opportunities for collaboration among members.
APhA represents the pharmacy profession at the national level, contributing to the development of guidelines, policies, and best practices aimed at elevating the profession while improving patient care throughout the community.
Frequently Asked Questions
Why is the APhA concerned about the hepatitis B vaccination decision?
The APhA believes the removal of the universal birth dose puts infants at risk who could otherwise benefit from this important vaccination.
What are the risks associated with hepatitis B in infants?
Infants infected with HBV have a high chance of becoming chronic carriers and facing severe health complications, including liver failure and cancer.
What role do pharmacists play in vaccination?
Pharmacists are vital in administering vaccines and educating the public about vaccine benefits, including hepatitis B vaccination.
How safe are the hepatitis B vaccines?
Hepatitis B vaccines are well-established and recognized for their safety and effectiveness across various age groups.
What can be done to support childhood vaccination efforts?
Advocacy for evidence-based immunization policies, community education, and strong support for the established immunization schedule can enhance vaccination efforts.
